U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 3C18H33O2.Fe
Molecular Weight 900.205
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 3
Charge 0

SHOW SMILES / InChI
Structure of FERRIC OLEATE

SMILES

[Fe+3].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O

InChI

InChIKey=HOIQWTMREPWSJY-GNOQXXQHSA-K
InChI=1S/3C18H34O2.Fe/c3*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h3*9-10H,2-8,11-17H2,1H3,(H,19,20);/q;;;+3/p-3/b3*10-9-;

HIDE SMILES / InChI

Molecular Formula Fe
Molecular Weight 55.845
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C18H33O2
Molecular Weight 281.4534
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

3-Bromcamphor is camphor derivative, that used in Russia as a calming agent and an indirect anticoagulant in the form of tablets based on both left-hand-rotating and racemic isoforms of this compound. The use of racemic bromcamphor instead of the optically active forms is explained by the much (almost tenfold) lower cost at a comparable physiological activity of the former drug. Racemic bromcamphor has a lower melting point as compared to that of the left-hand-rotating isomer (48 – 53°C versus 71 – 76°C, respectively) and is susceptible to fusion at room temperature

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.5 nM [IC50]
5.0 nM [IC50]
6.0 nM [IC50]
920.0 nM [IC50]
0.5 nM [IC50]
0.5 nM [IC50]
6.0 nM [IC50]
13.0 nM [IC50]
50.0 nM [IC50]
0.5 nM [IC50]
0.9 nM [IC50]
1.2 nM [IC50]
Target ID: Q92993|||Q9BWK7
Gene ID: 10524.0
Gene Symbol: KAT5
Target Organism: Homo sapiens (Human)
Conditions
PubMed

PubMed

TitleDatePubMed
Reactivity of endo-3-bromocamphor with sulfur-centered nucleophiles by an electron transfer mechanism. Electrophilic behaviour of the 3-camphoryl radical.
2011 Apr 21
Characterization of the cellular action of the MSK inhibitor SB-747651A.
2012 Jan 1
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
BAY-299 has <1uM activity in the BRD1 and TAF1 NanoBRET™ cell assays
Substance Class Chemical
Created
by admin
on Wed Jul 05 23:00:13 UTC 2023
Edited
by admin
on Wed Jul 05 23:00:13 UTC 2023
Record UNII
C1NE1661VN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERRIC OLEATE
Common Name English
9-OCTADECENOIC ACID (9Z)-, IRON(3+) SALT (3:1)
Common Name English
IRON TRIOLEATE
Common Name English
IRON OLEATE, (FE 3+)-
Common Name English
NSC-112238
Code English
OLEIC ACID, IRON(3+) SALT
Common Name English
9-OCTADECENOIC ACID (Z)-, IRON(3+) SALT
Common Name English
9-OCTADECENOIC ACID (9Z)-, IRON(3+) SALT
Common Name English
IRON(III) OLEATE
Common Name English
Code System Code Type Description
FDA UNII
C1NE1661VN
Created by admin on Wed Jul 05 23:00:13 UTC 2023 , Edited by admin on Wed Jul 05 23:00:13 UTC 2023
PRIMARY
NSC
112238
Created by admin on Wed Jul 05 23:00:13 UTC 2023 , Edited by admin on Wed Jul 05 23:00:13 UTC 2023
PRIMARY
CAS
1120-45-2
Created by admin on Wed Jul 05 23:00:13 UTC 2023 , Edited by admin on Wed Jul 05 23:00:13 UTC 2023
PRIMARY
PUBCHEM
14009126
Created by admin on Wed Jul 05 23:00:13 UTC 2023 , Edited by admin on Wed Jul 05 23:00:13 UTC 2023
PRIMARY
ECHA (EC/EINECS)
214-309-5
Created by admin on Wed Jul 05 23:00:13 UTC 2023 , Edited by admin on Wed Jul 05 23:00:13 UTC 2023
PRIMARY
CAS
23335-74-2
Created by admin on Wed Jul 05 23:00:13 UTC 2023 , Edited by admin on Wed Jul 05 23:00:13 UTC 2023
NON-SPECIFIC STOICHIOMETRY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE